Supriya Lifescience Ltd. News and Updates

Name: Latest research reports of Supriya Lifescience Ltd. authored by Hem Securities and published by - Trendlyne research reports.
Item: Supriya Lifescience Ltd.
Rating: 3
Author: Hem Securities

Keep track of all breaking news on Supriya Lifescience Ltd. from all sources in a single place.

Load latest

Supriya Lifescience Ltd.

17 Dec 2021

623.30

-0.57%

Supriya Lifescience IPO subscribed 5.69 times on Day 2 of offer

Business Standard

The initial share sale of Supriya Lifescience Limited received 5.69 times subscription on the second day of offer on Friday. The initial public offer (IPO) received bids for 8,27,05,698 shares against 1,45,28,299 shares on offer, as per NSE data. The category for Retail Individual Investor (RIIs) was subscribed 25.38 times, while non-institutional investors received 2.90 times subscription, and Qualified Institutional Buyers (QIBs) 53 per cent. The initial public offer of Supriya Lifescience was fully subscribed within a few hours of opening for subscription on Thursday on the back of a strong response from retail investors. The initial public offer has a fresh issue of up to Rs 200 crore and an offer-for-sale of up to Rs 500 crore. Price range for the offer is at Rs 265-274 per share. On Wednesday, the company raised Rs 315 crore from anchor investors. The proceeds from the fresh issue will be used for funding capital expenditure requirements, debt repayment, and general corpor

Supriya Lifescience .. has an average target of 740.00 from 1 broker.

Supriya Lifescience Ltd.

17 Dec 2021

623.30

-0.57%

Subscribe to Supriya Lifescience: Motilal Oswal

Moneycontrol

Motilal Oswal has come out with its report on Supriya Lifescience. The research firm has recommended to ''Subscribe'' the ipo in its research report as on December 15, 2021.

Supriya Lifescience Ltd. is trading below all available SMAs

Subscribe to Supriya Lifescience: Geojit

Moneycontrol | 17 Dec 2021 4 more

Supriya Lifescience Ltd.

16 Dec 2021

623.30

-0.57%

Supriya Lifescience IPO Subscribed 2.33 Times On First Day Of Issue

NDTV Profit

The IPO of Supriya Lifescience was subscribed 2.33 times on Thursday, the first day of its issue

Number of FII/FPI investors increased from 85 to 98 in Mar 2025 qtr.

Data Patterns IPO subscribed 120 times, generates Rs 50,000 cr in bids

Business Standard | 16 Dec 2021 9 more

Supriya Lifescience Ltd.

16 Dec 2021

623.30

-0.57%

Supriya Lifescience IPO opens today. GMP, other details in 10 points

livemint

Supriya Lifescience IPO GMP today is 275 that means grey market is expecting Supriya Lifescience share listing at around 549, believe market observers

Supriya Lifescience .. has an average target of 740.00 from 1 broker.

Supriya Lifescience Ltd.

16 Dec 2021

623.30

-0.57%

SUPRIYA LIFESCIENCES LTD.

IPO Note: Supriya Lifescience Ltd.

Hem Securities

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. As of October 31, 2021, company have niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic,...

Supriya Lifescience Ltd. has gained 55.77% in the last 1 Year

Supriya Lifescience Ltd.

16 Dec 2021

623.30

-0.57%

Supriya Lifescience : IPO

IPO Note: Supriya Lifescience Ltd.

ICICI Securities Limited

Supriya has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between FY17 and FY21. SLL is among the largest exporters of Salbutamol Sulphate in India contributing to...

Number of FII/FPI investors increased from 85 to 98 in Mar 2025 qtr.

Supriya Lifescience Ltd.

15 Dec 2021

623.30

-0.57%

Pre-IPO Analyst Meet for Supriya Lifescience

Pre-IPO Conference Call with Supriya Lifescience. Listen to the full transcript.

Supriya Lifescience Ltd.

15 Dec 2021

623.30

-0.57%

Supriya Lifescience Ltd

IPO Subscribe: Supriya Lifescience Ltd.

Angel Broking

Supriya Lifescience Limited was incorporated in March 2008 by Satish Waman Wagh. Company is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs). Supriya Lifescience Limited focus on research and development along with this company focus is on diverse therapeutic areas and niche products. Company has niche product offerings of 38

Supriya Lifescience Ltd. is trading below all available SMAs

Supriya Lifescience Ltd.

15 Dec 2021

623.30

-0.57%

SUPRIYA LIFESCIENCE LTD.

IPO Note: Supriya Lifescience Ltd.

Ventura

IPO NOTE

Number of FII/FPI investors increased from 85 to 98 in Mar 2025 qtr.

Supriya Lifescience Ltd.

15 Dec 2021

623.30

-0.57%

Supriya Lifescience Ltd. IPO Note

IPO Note: Supriya Lifescience Ltd.

Ashika Research

Public issue of 2,55,47,445 Equity shares of Face value Total Public 2 each, (Comprising of fresh issue of 72,99,270 Equity Shares* (Rs. 200 cr.) and Offer for Sale of 1,82,48,175 Equity Shares* (Rs. 500 cr.) by Selling Shareholder)....

Supriya Lifescience Ltd. is trading below all available SMAs

VOTE: Is Supriya Lifescience Ltd. worth buying?

97 Votes:

Buy 85.57%

Sell 7.22%

Hold 7.22%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf

25.97% Fall from 52W High

Supriya Lifescience Ltd. News and Updates

Keep track of all breaking news on Supriya Lifescience Ltd. from all sources in a single place.